Xenon Pharmaceuticals XENE
NASDAQ XENE
$38.93 +1.74 (+4.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Return on Equity [ROE] (2014 - 2026)

Updated

Xenon Pharmaceuticals' Return on Equity [ROE] was -31.72% in Q2 2026, up 9.87 percentage points from -41.59% a year earlier and up 8.20 percentage points from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Xenon Pharmaceuticals came in at -51.76%, down 23.91 percentage points from FY2024.

  • Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -29.86 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -27.85% in FY2024 (-5.73 pp), -22.12% in FY2023 (-2.40 pp), -19.72% in FY2022 (+2.15 pp) and -21.87% in FY2021 (+0.03 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2024.
  • Compared with a year earlier, Return on Equity [ROE] was higher in two of the last eight quarters, with an average year-over-year change of -11.15 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2022 (a gain of 11.19 percentage points); the worst was Q4 2025 (a drop of 30.44 percentage points).
  • Per Business Quant data, XENE's Return on Equity [ROE] in the three quarters before Q2 2026 was -39.92% (Q1 2026), -60.62% (Q4 2025) and -51.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn - -31.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.72%
Mar 31, 2026 -39.92%
Dec 31, 2025 -60.62%
Sep 30, 2025 -51.33%
Jun 30, 2025 -41.59%
Mar 31, 2025 -34.47%
Dec 31, 2024 -30.18%
Sep 30, 2024 -25.99%
Jun 30, 2024 -22.99%
Mar 31, 2024 -20.77%
Dec 31, 2023 -23.32%
Sep 30, 2023 -27.29%
Jun 30, 2023 -24.56%
Mar 31, 2023 -20.94%
Dec 31, 2022 -17.00%
Sep 30, 2022 -14.76%
Jun 30, 2022 -13.83%
Mar 31, 2022 -15.16%
Dec 31, 2021 -19.75%
Sep 30, 2021 -25.95%
API Access

Xenon Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XENE&period=max&api_key=YOUR_API_KEY